The role
0301Supporting and managing HEOR activities across hematology assets in Europe and New Markets, delivering evidence for HTA, reimbursement, and broader evidence needs.
02Collaborating with cross-functional teams to identify evidence gaps and prioritize HEOR activities based on regional and local requirements.
03Developing and executing HEOR evidence-generation activities, including comparative effectiveness research, real-world evidence, and economic analyses.
04Supporting the development, review, and quality assurance of HEOR studies and deliverables, including protocols, analysis plans, reports, and publications.
05Contributing to European HTA and EU Joint Clinical Assessment (JCA) strategies, including planning and executing required evidence-generation activities.
06Supporting JCA PICO planning by assessing populations, subgroups, comparators, outcomes, evidence gaps, and feasibility considerations.
07Leading or supporting comparative evidence generation for JCA and other HTA requirements.
08Evaluating clinical, external, and real-world data with internal and external stakeholders to address evidence gaps and inform evidence-generation approaches.
09Managing external HEOR vendors and projects, overseeing scope, methodology, timelines, deliverables, and quality control.
10Supporting the interpretation and communication of HEOR evidence, including methodological considerations and implications for HTA decision-making.
11Providing additional HEOR support across the hematology portfolio as business priorities evolve.
